BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33107436)

  • 1. Etiology of severe short stature below -3 SDS in a screened Finnish population.
    Kärkinen J; Miettinen PJ; Raivio T; Hero M
    Eur J Endocrinol; 2020 Nov; 183(5):481-488. PubMed ID: 33107436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected high frequency of skeletal dysplasia in idiopathic short stature and small for gestational age patients.
    Flechtner I; Lambot-Juhan K; Teissier R; Colmenares A; Baujat G; Beltrand J; Ajaltouni Z; Pauwels C; Pinto G; Samara-Boustani D; Simon A; Thalassinos C; Le Merrer M; Cormier-Daire V; Polak M
    Eur J Endocrinol; 2014 May; 170(5):677-84. PubMed ID: 24536087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiologies of short stature in a pediatric endocrine clinic in Southern Thailand.
    Saengkaew T; McNeil E; Jaruratanasirikul S
    J Pediatr Endocrinol Metab; 2017 Nov; 30(12):1265-1270. PubMed ID: 29127766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth status of children and adolescents born small for gestational age at full term in Korea: data from the KNHANES-V.
    Kim JH; Kim DH; Lim JS
    J Pediatr Endocrinol Metab; 2020 May; 33(6):743-750. PubMed ID: 32447332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
    Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
    Child CJ; Quigley CA; Cutler GB; Moore WV; Wintergerst KA; Ross JL; Rosenfeld RG; Blum WF
    Horm Res Paediatr; 2019; 91(4):241-251. PubMed ID: 31185471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of reasons of short stature in own material].
    Majcher A; Bielecka-Jasiocha J; Pyrzak B
    Pediatr Endocrinol Diabetes Metab; 2009; 15(3):152-6. PubMed ID: 20384174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
    J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Value of IAP 2015, IAP 2007 and WHO Growth Charts in Identifying Pathological Short Stature.
    Patel R; Dave C; Agarwal N; Mendpara H; Shukla R; Bajpai A
    Indian Pediatr; 2021 Feb; 58(2):149-151. PubMed ID: 33632946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of children born small for gestational age with short stature who qualify for growth hormone treatment.
    Tamaro G; Pizzul M; Gaeta G; Servello R; Trevisan M; Böhm P; Materassi PMA; Macaluso A; Valentini D; Pellegrin MC; Barbi E; Tornese G
    Ital J Pediatr; 2021 Apr; 47(1):82. PubMed ID: 33794966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology of short stature in Indian children and an assessment of the growth hormone-insulin-like growth factor axis in children with idiopathic short stature.
    Kumar A; Pal A; Kalaivani M; Gupta N; Jain V
    J Pediatr Endocrinol Metab; 2018 Sep; 31(9):1009-1017. PubMed ID: 30130251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy with GnRH analogue and growth hormone increases adult height in children with short stature and normal pubertal onset.
    Li S; Wang X; Zhao Y; Ji W; Mao J; Nie M; Wu X
    Endocrine; 2020 Sep; 69(3):615-624. PubMed ID: 32533506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of different definitions of growth response in short prepubertal children treated with growth hormone.
    Bang P; Bjerknes R; Dahlgren J; Dunkel L; Gustafsson J; Juul A; Kriström B; Tapanainen P; Aberg V
    Horm Res Paediatr; 2011; 75(5):335-45. PubMed ID: 21228552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of growth hormone treatment on height in children with idiopathic short stature.
    Jeong HR; Shim YS; Lee HS; Hwang JS
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):629-33. PubMed ID: 24810558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of small for gestational age (SGA) and short stature in children born SGA who qualify for growth hormone treatment at 3 years of age: Population-based study.
    Fujita K; Nagasaka M; Iwatani S; Koda T; Kurokawa D; Yamana K; Nishida K; Taniguchi-Ikeda M; Uchino E; Shirai C; Iijima K; Morioka I
    Pediatr Int; 2016 May; 58(5):372-6. PubMed ID: 26617415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of growth hormone treatment on craniofacial growth in children: Idiopathic short stature versus growth hormone deficiency.
    Choi SH; Fan D; Hwang MS; Lee HK; Hwang CJ
    J Formos Med Assoc; 2017 Apr; 116(4):313-321. PubMed ID: 27421175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.